Sermorelin (10mg vials)

Description

Sermorelin is a chemically synthesized peptide that reproduces the first 29 residues of native human growth hormone-releasing hormone. This shortened sequence retains the portion of the parent hormone responsible for engaging the GHRH receptor, which makes it a frequently referenced reference compound in studies of receptor binding and pituitary signaling.

Because it represents the minimal active fragment of GHRH, Sermorelin is often used as a structural touchstone in work that compares truncated peptides against the full-length hormone. Investigators use it to probe how the N-terminal region drives receptor recognition and downstream signal transduction in cell-based models. Its molecular weight is approximately 3358 Da.

As one of the earliest characterized GHRH analogs, Sermorelin holds a well-documented place in the peptide research record. Peer-reviewed background on GHRH biology and this peptide specifically can be located through public scientific databases such as PubMed and PMC.

• GHRH receptor pharmacology, including binding kinetics and cellular signaling pathways
• Structure-activity comparisons between the 1-29 fragment and full-length GHRH
• Anterior pituitary cell responsiveness to native versus synthetic GHRH peptides
• Minimal-active-sequence and peptide truncation studies
• Comparative analysis alongside other modified GHRH analogs in laboratory settings

Each lot is supplied as lyophilized powder at 99%+ purity, confirmed by HPLC and mass spectrometry, with a certificate of analysis available. For best stability, store the sealed vial cold and reconstitute only with appropriate solvents under controlled laboratory conditions.

Research Use Only: This material is supplied strictly for laboratory research. Not for human or animal consumption. It is not a drug, food, supplement, or cosmetic and has not been approved by the FDA.